3,4-dihydroxyphenylethanol has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aligiannis, N; Argyropoulou, A; Christoforidou, N; Gaboriaud-Kolar, N; Ioannou, K; Lemus, C; Paronis, E; Samara, P; Skaltsounis, AL; Tsitsilonis, O; Vougogiannopoulou, K | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylethanol and B16 Melanoma
Article | Year |
---|---|
New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Iridoid Glucosides; Iridoids; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |